P

Inventor

FERREIRA MANUEL ALLEN REVEZ

US14 patents
⚠️ This page may combine multiple inventors who share the name “FERREIRA MANUEL ALLEN REVEZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

13 patents
US11957704B2Apr 16, 2024

Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors

REGENERON PHARMA2 citations70
US11939635B2Mar 26, 2024

Treatment of obesity in subjects having variant nucleic acid molecules encoding Calcitonin Receptor (CALCR)

REGENERON PHARMA2 citations70
US11759476B2Sep 19, 2023

Methods of treating metabolic disorders and cardiovascular disease with Inhibin Subunit Beta E (INHBE) inhibitors

REGENERON PHARMA2 citations70
US12577562B2Mar 17, 2026

Treatment of glaucoma with Rho Guanine Nucleotide Exchange factor 12 (ARHGEF12) inhibitors

REGENERON PHARMA0 citations59
US12258627B2Mar 25, 2025

Kelch domain containing 7B (KLHDC7B) variants and uses thereof

REGENERON PHARMA0 citations59
US11820982B2Nov 21, 2023

Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

REGENERON PHARMA1 citations59
US11674177B2Jun 13, 2023

Kelch domain containing 7B (KLHDC7B) variants and uses thereof

REGENERON PHARMA1 citations59
US11752197B2Sep 12, 2023

Macrophage stimulating 1 receptor (MST1R) variants and uses thereof

REGENERON PHARMA0 citations58
US12370257B2Jul 29, 2025

Materials and methods of treating MHC-I-opathy risk haplotypes

REGENERON PHARMA0 citations52
US12049670B2Jul 30, 2024

Proprotein convertase subtilisin/kexin type 1 (PCSK1) variants and uses thereof

REGENERON PHARMA0 citations49
US12186378B2Jan 7, 2025

Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists

REGENERON PHARMA0 citations47
US12378557B2Aug 5, 2025

Treatment of sepsis with PCSK9 and LDLR modulators

REGENERON PHARMA0 citations46
US12584174B2Mar 24, 2026

Treatment of psoriasis with interferon induced Helicase C domain 1 (IFIH1) inhibitors

REGENERON PHARMA0 citations37

REGENERAN PHARMACEUTICALS INC

1 patent